# Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer

> **NCT00292045** · PHASE1 · COMPLETED · sponsor: **Ludwig Institute for Cancer Research** · enrollment: 15 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** NY-ESO-1 protein/CpG 7909

## Key facts

- **NCT ID:** NCT00292045
- **Lead sponsor:** Ludwig Institute for Cancer Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-27
- **Primary completion:** 2006-01-09
- **Final completion:** 2006-01-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292045, "Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00292045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*